Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

Clinical trial NCT00015951 · COMPLETED

Trial details

NCT number: NCT00015951
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes

Start date: 2001-04-01
Primary completion: 2003-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.